Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Mellini

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Expert Opinion on Therapeutic Patents|December 2, 2014
Sirtuin modulators: an updated patent review (2012 - 2014)Paolo Mellini, Sergio Valente, Antonello Mai
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 9, 2014
Studying SIRT6 regulation using H3K56 based substrate and small moleculesPiia Kokkonen, Minna Rahnasto-Rilla, Paolo Mellini, et al.
BMC Cancer|August 8, 2018
Novel small molecule SIRT2 inhibitors induce cell death in leukemic cell linesTomohiro Kozako, Paolo Mellini, Takeo Ohsugi, et al.
Neuropharmacology|February 11, 2017
SIRT2 inhibition modulate glutamate and serotonin systems in the prefrontal cortex and induces antidepressant-like actionMercedes Erburu, Irene Muñoz-Cobo, Teresa Diaz-Perdigon, et al.
Journal of Medicinal Chemistry|August 10, 2013
Screen of pseudopeptidic inhibitors of human sirtuins 1-3: two lead compounds with antiproliferative effects in cancer cellsPaolo Mellini, Tarja Kokkola, Tiina Suuronen, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|April 22, 2014
Quantitative insights for the design of substrate-based SIRT1 inhibitorsPiia Kokkonen, Paolo Mellini, Olli Nyrhilä, et al.
Chemical Science|October 10, 2017
Potent mechanism-based sirtuin-2-selective inhibition by an <i>in situ</i>-generated occupant of the substrate-binding site, "selectivity pocket" and NAD<sup>+</sup>-binding sitePaolo Mellini, Yukihiro Itoh, Hiroki Tsumoto, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|April 25, 2018
Pyrazole-based inhibitors of enhancer of zeste homologue 2 induce apoptosis and autophagy in cancer cellsPaolo Mellini, Biagina Marrocco, Diana Borovika, et al.
European Journal of Medicinal Chemistry|February 11, 2012
Synthesis and antifungal activity of a new series of 2-(1H-imidazol-1-yl)-1-phenylethanol derivativesDaniela De Vita, Luigi Scipione, Silvano Tortorella, et al.
Chemmedchem|October 25, 2013
Carprofen analogues as sirtuin inhibitors: enzyme and cellular studiesPaolo Mellini, Vincenzo Carafa, Barbara Di Rienzo, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Expert Opinion on Therapeutic Patents|December 2, 2014
Sirtuin modulators: an updated patent review (2012 - 2014)Paolo Mellini, Sergio Valente, Antonello Mai
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 9, 2014
Studying SIRT6 regulation using H3K56 based substrate and small moleculesPiia Kokkonen, Minna Rahnasto-Rilla, Paolo Mellini, et al.
BMC Cancer|August 8, 2018
Novel small molecule SIRT2 inhibitors induce cell death in leukemic cell linesTomohiro Kozako, Paolo Mellini, Takeo Ohsugi, et al.
Neuropharmacology|February 11, 2017
SIRT2 inhibition modulate glutamate and serotonin systems in the prefrontal cortex and induces antidepressant-like actionMercedes Erburu, Irene Muñoz-Cobo, Teresa Diaz-Perdigon, et al.
Journal of Medicinal Chemistry|August 10, 2013
Screen of pseudopeptidic inhibitors of human sirtuins 1-3: two lead compounds with antiproliferative effects in cancer cellsPaolo Mellini, Tarja Kokkola, Tiina Suuronen, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|April 22, 2014
Quantitative insights for the design of substrate-based SIRT1 inhibitorsPiia Kokkonen, Paolo Mellini, Olli Nyrhilä, et al.
Chemical Science|October 10, 2017
Potent mechanism-based sirtuin-2-selective inhibition by an <i>in situ</i>-generated occupant of the substrate-binding site, "selectivity pocket" and NAD<sup>+</sup>-binding sitePaolo Mellini, Yukihiro Itoh, Hiroki Tsumoto, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|April 25, 2018
Pyrazole-based inhibitors of enhancer of zeste homologue 2 induce apoptosis and autophagy in cancer cellsPaolo Mellini, Biagina Marrocco, Diana Borovika, et al.
European Journal of Medicinal Chemistry|February 11, 2012
Synthesis and antifungal activity of a new series of 2-(1H-imidazol-1-yl)-1-phenylethanol derivativesDaniela De Vita, Luigi Scipione, Silvano Tortorella, et al.
Chemmedchem|October 25, 2013
Carprofen analogues as sirtuin inhibitors: enzyme and cellular studiesPaolo Mellini, Vincenzo Carafa, Barbara Di Rienzo, et al.
Pageof 2